コンテンツへスキップ
Merck

[Drug treatments, from chlorpromazine to new molecules].

Soins. Psychiatrie (2013-06-14)
Adeline Gaillard, Marie-France Poirier
要旨

The history of drug treatments, and particularly the discovery of certain molecules, led toan evolution in psychiatric practices. The discovery of the therapeutic properties of chlorpromazine in 1952 by Jean Delay and Pierre Deniker revolutionised the relational process between patients and caregivers.The perspectives are encouraging, notably in the areas of schizophrenia and mood disorders.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
クロルプロマジン 塩酸塩, ≥98% (TLC)
Supelco
クロルプロマジン 塩酸塩, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
クロルプロマジン 塩酸塩, meets USP testing specifications
Supelco
クロルプロマジン 塩酸塩, VETRANAL®, analytical standard
クロルプロマジン 塩酸塩, European Pharmacopoeia (EP) Reference Standard